<DOC>
	<DOCNO>NCT01120314</DOCNO>
	<brief_summary>Primary Objective : - To study effect mild , moderate severe renal impairment pharmacokinetics Otamixaban . Secondary Objective : - To assess pharmacodynamic effect Otamixaban subject mild , moderate severe renal impairment match subject normal renal function .</brief_summary>
	<brief_title>Pharmacokinetic , Pharmacodynamic Tolerability Study Otamixaban Patients With Mild , Moderate Severe Renal Impairment</brief_title>
	<detailed_description>The study period one subject broken follow : - 2 28 day screen , - 1 day treatment , - 8 11 day follow-up start infusion . There 5 day unit start day start infusion .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Otamixaban</mesh_term>
	<criteria>Inclusion criterion : Subject renal impairment : Mild , moderate severe renal impairment define Creatinine Clearance ( CrCl ) 50 80 , 30 50 &lt; 30 mL/min respectively , base CockcroftGault formula , Body weight 50.0 kg 115.0 kg inclusive male , 40.0 kg 95.0 kg inclusive female , Body Mass Index 18.0 34.9 kg/m2 inclusive . Stable chronic renal impairment define CockcroftGault formula , Vital sign , cardiac function laboratory parameter within acceptable range . Or match subject ( age , gender body weight ) normal renal function ( define CrCl &gt; 80 mL/min ) certify healthy physical examination , medical history laboratory finding . If female , subject must use double contraception method , except sterilize 3 month postmenopausal . Exclusion criterion : Uncontrolled clinically relevant cardiovascular , pulmonary , gastrointestinal , metabolic , hematological , neurological , psychiatric , systemic , ocular , gynecologic ( female ) infectious disease , sign acute illness . Active hepatitis , hepatic insufficiency . Acute renal failure , nephrotic syndrome . History current hematuria urologic origin . Subject require dialysis study . History presence drug alcohol abuse within two year inclusion . Smoking 15 cigarette equivalent per day . Any significant change chronic treatment medication within 14days inclusion . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>